Ingredient or product comparison
GHK-Cu Dosage Comparison: Clinical vs Cosmetic Formulations
Research-grade peptide (lab use) 5–10% in solution 0.8–1.6% elemental copper Once daily post-procedure Used in wound healing studies; not intended for intact skin cosmetic use Exceeds cosmetic safety thresholds. Irritation risk outweighs benefit for aesthetic
This source-based comparison does not add ratings or recommend a winner.
- Research-grade peptide (lab use)
- 5–10% in solution
- 0.8–1.6% elemental copper
- Once daily post-procedure
- Used in wound healing studies; not intended for intact skin cosmetic use
- Exceeds cosmetic safety thresholds. Irritation risk outweighs benefit for aesthetic use
- Clinical dermatology formulations
- 2–3% GHK-Cu
- 0.3–0.5% copper
- Once daily
- Peer-reviewed studies show 60–70% collagen density increase at 12 weeks
- Optimal balance of efficacy and tolerability. This is the benchmark
- Premium cosmetic serums
- 1–2% GHK-Cu
- 0.15–0.3% copper
- Once or twice daily
- Limited independent verification; mostly brand-funded trials
- Effective if formulation includes adequate penetration vehicle
- Mass-market 'copper peptide' products
- 0.1–0.5% GHK-Cu
- 0.01–0.08% copper
- Twice daily
- No measurable collagen improvement in controlled trials
- Below clinical threshold. Functions as moisturizer with trace peptide
- DIY formulations (home mixing)
- Variable (0.5–5%)
- Variable
- User-dependent
- No standardization or sterility verification
- High contamination and dosage error risk. Not recommended
- The bottom line: if a product doesn't specify GHK-Cu concentration by weight (not just 'contains copper peptides'), assume it's below the 1% clinical threshold. Marketing terms like 'advanced copper complex' or 'peptide-infused' are red flags. They signal formulations that use trace peptide amounts for label claims without therapeutic dosing.